Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > In the past, Medipharm has issued a feel good

<< Previous

Bullboard Posts

Next >>

Post by mdjbrownon May 06, 2024 1:02pm

122 Views

Post# 36025243

In the past, Medipharm has issued a feel good

press release prior to the Financials being reported.

Any guesses prior to Q1 Fins release?

Improved sales
ANVISA update
Germany / Dronbinol
Rescheduling benefits
Clinical Trial updates
International partner(s)

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023